BALAXINSEBALAXI PHARMACEUTICALS LIMITEDMediumNeutral
Announced Wed, 25 Mar · 13:14 IST

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Appointment of Mr AMAN PUROHIT as Company Secretary & Compliance Officer of the company w.e.f. March 25, 2026.

Management Changes View source PDF

BALAXI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.9%1-day move
₹18.06
prior close
₹17.86
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7-0.2-0.2-0.2-5.9-12.5+4.1+15.7+21.8+32.4+53.5+46.7+41.6+29.0
Up moveDown movePending
AI summary

Balaxi Pharmaceuticals Limited has appointed Mr. Aman Purohit as the new Company Secretary and Compliance Officer of the company, effective March 25, 2026. The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. Mr. Purohit is an Associate Member of ICSI with 6 years of post-qualification experience in secretarial compliance, mergers, acquisitions, corporate restructuring, and due diligence. He previously worked at Patil Rail Infrastructure Private Limited and Re Sustainability IWM Solutions Limited, both based in Hyderabad.

Likely market impact

This is a routine key managerial personnel (KMP) appointment and is unlikely to have any material impact on the stock price. It strengthens the company's compliance and secretarial functions.